Writing and erasing MYC ubiquitination and SUMOylation

Area of Science:

• Molecular Biology
• Cancer Biology
• Biochemistry

Background:

• The transcription factor c-MYC (MYC) is crucial in human cancers and normal cellular functions.
• MYC protein levels are tightly regulated due to its short half-life, primarily via the ubiquitin-proteasome system.
• Ubiquitination and SUMOylation are key post-translational modifications influencing MYC stability and activity.

Purpose of the Study:

• To review the complex regulation of MYC biology by ubiquitination and SUMOylation.
• To elucidate the crosstalk between MYC ubiquitination and SUMOylation.
• To understand the role of this regulatory network in tumorigenesis.

Main Methods:

• Literature review of studies on MYC post-translational modifications.
• Analysis of research on ubiquitin ligases and deubiquitinating enzymes acting on MYC.
• Examination of studies investigating SUMOylation/deSUMOylation of MYC.
• Review of evidence for crosstalk between ubiquitination and SUMOylation of MYC.

Main Results:

• Over a dozen ubiquitin ligases and several deubiquitinating enzymes regulate MYC ubiquitination.
• SUMOylation and deSUMOylation also impact MYC protein stability and activity.
• Evidence indicates a significant crosstalk between MYC ubiquitination and SUMOylation pathways.
• Deregulation of this network is implicated in cancer development.

Conclusions:

• MYC biology is intricately regulated by dynamic ubiquitination and SUMOylation processes.
• The crosstalk between these modifications is critical for controlling MYC levels and activity.
• Aberrant regulation of the MYC ubiquitination-SUMOylation network is a potential driver of tumorigenesis.